WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
฿ 5.20
0.00%
(0.00) Siku 1
15 Okt, 16:40:00 GMT +7 · THB
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya WUXI06...
Fungua
฿ 5.25
Juu
฿ 5.35
Chini
฿ 5.05
Mtaji wa soko
198.43B
Wastani wa kiasi cha mauzo
elfu 93.60
Kiasi cha mauzo ya hisa
elfu 288.50
Juu kwa wiki 52
฿ 6.25
Chini kwa wiki 52
฿ 3.02
Hisa za wawekezaji
4.12B
Idadi ya wafanyakazi
elfu 15
Fungua
฿ 5.25
Juu
฿ 5.35
Chini
฿ 5.05
Mtaji wa soko
198.43B
Wastani wa kiasi cha mauzo
elfu 93.60
Kiasi cha mauzo ya hisa
elfu 288.50
Juu kwa wiki 52
฿ 6.25
Chini kwa wiki 52
฿ 3.02
Hisa za wawekezaji
4.12B
Idadi ya wafanyakazi
elfu 15
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
medwatch.com
·
saa 1 iliyopita
Iambic Therapeutics raises USD 150m in Nasdaq IPO
The Globe and Mail
·
dakika 44 zilizopita
TNL Mediagene Regains Compliance with Nasdaq Minimum Bid Price Requirement
Barron's
·
dakika 1 iliyopita
S&P 500 Futures Up in Premarket Trading; NVR, Cooper Lag
Yahoo Finance
·
dakika 28 zilizopita
What Invesco NASDAQ 100 ETF (QQQM) Bought: NVIDIA Leads on Oct. 14
Wasifu
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Kuhusu Wuxi Biologics (Cayman) Inc. KKPS DR
Afisa Mkuu Mtendaji (CEO)Zhisheng Chen
Wafanyakazielfu 14.7
Lilianzishwa2010
Makao makuu-
Sekta-
Tovutiwuxibiologics.com